PortfoliosLab logoPortfoliosLab logo
SOAGY vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SOAGY vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sartorius Aktiengesellschaft (SOAGY) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SOAGY achieves a 0.41% return, which is significantly lower than NVS's 10.91% return.


SOAGY

1D
1.98%
1M
10.02%
YTD
0.41%
6M
-2.91%
1Y
25.17%
3Y*
-6.05%
5Y*
-5.58%
10Y*

NVS

1D
3.30%
1M
1.99%
YTD
10.91%
6M
15.47%
1Y
30.77%
3Y*
18.32%
5Y*
14.79%
10Y*
10.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SOAGY vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SOAGY
Sartorius Aktiengesellschaft
0.41%30.06%-39.37%-6.83%-37.01%61.68%-13.82%
NVS
Novartis AG
10.91%46.95%0.02%16.14%8.06%-3.65%8.01%

Correlation

The correlation between SOAGY and NVS is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Oct 14, 2020

0.11

The correlation between SOAGY and NVS shifts across timeframes, from 0.11 (all time) to 0.25 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SOAGY:

$20.06B

NVS:

$284.33B

EPS

SOAGY:

$0.47

NVS:

$6.99

PE Ratio

SOAGY:

122.92

NVS:

21.23

PEG Ratio

SOAGY:

8.90

NVS:

1.43

PS Ratio

SOAGY:

5.64

NVS:

5.13

PB Ratio

SOAGY:

7.36

NVS:

7.38

Total Revenue (TTM)

SOAGY:

$3.56B

NVS:

$56.05B

Gross Profit (TTM)

SOAGY:

$1.62B

NVS:

$42.19B

EBITDA (TTM)

SOAGY:

$998.48M

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SOAGY vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOAGY
SOAGY Risk / Return Rank: 6060
Overall Rank
SOAGY Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
SOAGY Sortino Ratio Rank: 5858
Sortino Ratio Rank
SOAGY Omega Ratio Rank: 5555
Omega Ratio Rank
SOAGY Calmar Ratio Rank: 6363
Calmar Ratio Rank
SOAGY Martin Ratio Rank: 6262
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 7878
Overall Rank
NVS Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7777
Sortino Ratio Rank
NVS Omega Ratio Rank: 7575
Omega Ratio Rank
NVS Calmar Ratio Rank: 7979
Calmar Ratio Rank
NVS Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOAGY vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sartorius Aktiengesellschaft (SOAGY) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SOAGYNVSDifference
Sharpe ratioReturn per unit of total volatility

-0.88

Sortino ratioReturn per unit of downside risk

-0.94

Omega ratioGain probability vs. loss probability

1.14

1.26

-0.13

Calmar ratioReturn relative to maximum drawdown

1.06

2.44

-1.38

Martin ratioReturn relative to average drawdown

2.15

6.09

-3.94

SOAGY vs. NVS - Sharpe Ratio Comparison

The current SOAGY Sharpe Ratio is 0.62, which is lower than the NVS Sharpe Ratio of 1.51. The chart below compares the historical Sharpe Ratios of SOAGY and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SOAGYNVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.62

1.51

-0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

0.79

-0.90

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.52

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.15

0.42

-0.57

Drawdowns

SOAGY vs. NVS - Drawdown Comparison

The maximum SOAGY drawdown since its inception was -69.53%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for SOAGY and NVS.


Loading charts...

Drawdown Indicators


SOAGYNVSDifference

Max Drawdown

Largest peak-to-trough decline

-69.53%

-42.10%

-27.43%

Max Drawdown (1Y)

Largest decline over 1 year

-23.78%

-12.65%

-11.13%

Max Drawdown (3Y)

Largest decline over 3 years

-53.66%

-19.95%

-33.71%

Max Drawdown (5Y)

Largest decline over 5 years

-69.53%

-20.42%

-49.11%

Max Drawdown (10Y)

Largest decline over 10 years

-26.03%

Current Drawdown

Current decline from peak

-54.25%

-9.31%

-44.94%

Average Drawdown

Average peak-to-trough decline

-39.41%

-10.93%

-28.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.75%

5.06%

+6.69%

Volatility

SOAGY vs. NVS - Volatility Comparison

Sartorius Aktiengesellschaft (SOAGY) has a higher volatility of 11.09% compared to Novartis AG (NVS) at 6.49%. This indicates that SOAGY's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SOAGYNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.09%

6.49%

+4.60%

Volatility (6M)

Calculated over the trailing 6-month period

30.83%

14.39%

+16.44%

Volatility (1Y)

Calculated over the trailing 1-year period

40.53%

20.52%

+20.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.51%

18.83%

+33.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.78%

19.61%

+30.17%

Dividends

SOAGY vs. NVS - Dividend Comparison

SOAGY's dividend yield for the trailing twelve months is around 0.30%, less than NVS's 3.22% yield.


PositionTTM20252024202320222021202020192018201720162015
NVS
Novartis AG
3.22%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%
SOAGY
Sartorius Aktiengesellschaft
0.30%0.26%0.36%0.42%0.35%0.07%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SOAGY vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Sartorius Aktiengesellschaft and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
913.89M
13.52B
(SOAGY) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

SOAGY vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between Sartorius Aktiengesellschaft and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20222023202420252026
46.1%
74.4%
Portfolio components
SOAGY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported a gross profit of 421.32M and revenue of 913.89M. Therefore, the gross margin over that period was 46.1%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

SOAGY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported an operating income of 153.48M and revenue of 913.89M, resulting in an operating margin of 16.8%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

SOAGY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sartorius Aktiengesellschaft reported a net income of 57.12M and revenue of 913.89M, resulting in a net margin of 6.3%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


SOAGY and NVS have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SOAGY has higher volatility (11.09%) compared to NVS (6.49%). In terms of maximum drawdown, SOAGY dropped -69.53% vs NVS's -42.10%.

NVS currently has the higher Sharpe Ratio (1.51 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SOAGY and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer